Perkantoran Hijau Arkadia, Tower A, Lt. 3
Jl. Letjen. TB. Simatupang Kav. 88 Jakarta 12520 Indonesia
Tel. : (021) 782-7660 (Hunting) Fax. : (021) 782-7663/4
Indonesia | English



Article
 
 

Jakarta, 28 May 2008

Drug Interactions : What You Should Know.

Drug Interactions : What You Should Know.

A drug interaction is a situation in which a substance affects the activity of a drug, i.e. the effects are increased or decreased, or they produce a new effect that neither produces on its own. Typically, interaction between drugs come to mind (drug-drug interaction). However, interactions may also exist between drugs & foods (drug-food interactions), as well as drugs & herbs (drug-herb interactions), drugs & micronutrients, and drugs & content of infusion solutions

Since most drug interactions have undesirable effects, generally speaking, drug interactions are avoided, due to the possibility of poor or unexpected outcomes. However, drug interactions have been deliberately used, such as co-administering probenecid with penicillin prior to mass production of penicillin.

A contemporary example of a drug interaction used as an advantage is the co-administration of carbidopa with levodopa (available as Carbidopa/levodopa). Levodopa is used in the management of Parkinson's disease and must reach the brain in an un-metabolized state to be beneficial. When given by itself, levodopa is metabolized in the peripheral tissues outside the brain, which decreases the effectiveness of the drug and increases the risk of adverse effects. However, since carbidopa inhibits the peripheral metabolism of levodopa, the co-administration of carbidopa with levodopa allows more levodopa to reach the brain un-metabolized and also reduces the risk of side effects.

Drug interactions may be the result of various processes. These processes may include alterations in the pharmacokinetics of the drug, such as alterations in the Absorption, Distribution, Metabolism, and Excretion (ADME) of a drug. Alternatively, drug interactions may be the result of the pharmacodynamic properties of the drug, e.g. the co-administration of a receptor antagonist and an agonist for the same receptor.

Metabolic drug interactions

Many drug interactions are due to alterations in drug metabolism. One notable system involved in metabolic drug interactions is the enzyme system comprising the cytochrome P450 oxidases. For example, There is a significant drug interaction between Ciprofloxacin and Methadone. Cipro may inhibit cytochrome P450 3A4 up to 65%. Since this is the primary enzyme responsible for metabolizing methadone, Cipro may elevate methadone levels significantly. This system may be affected by either enzyme induction or enzyme inhibition, as discussed in the examples below.

Enzyme induction - drug A induces the body to produce more of an enzyme which metabolises drug B. This reduces the effective concentration of drug B, which may lead to loss of effectiveness of drug B. Drug A effectiveness is not altered.
Enzyme inhibition - drug A inhibits the production of the enzyme metabolising drug B, thus an elevation of drug B occurs possibly leading to an overdose.
Bioavailability - drug A influences the absorption of drug B.
Unfortunately, given a tremendous amount of drugs in the market . it is impossible for any drug companies to check out the complete list of compatibility profile of their products with others. Accordingly, clinicians should always scrutinize prescribing information before administering medicine, particularly of new drugs.

Furthermore, the following link may offer some help when one wish to know drug-drug interactions:

http://www.drugs.com/drug_information.html

Drugs-Micronutrient Interaction

The serum concentration of electrolytes, microminerals and vitamins can be modified by certain drugs and should alert the physisians when abnormalities occur.

(APPENDIX)

IV Drugs Incompatibility

Some injectable drugs are not compatible with the content of infusion solutions. Typical examples are Sodium Bicarbonate in Lactated or Acetated Ringer Solutions.

To prevent incompatibilities, it is important to consider all the ways in which medications may interact outside of or inside the body. If you must mix a medication, always follow manufacturer’s instructions as to the correct volume and type of diluent; which solutions it may be added to for "piggy back" administration; and what flush solutions must be used in between administrations to prevent events like precipitation within the patient’s access device (for example, never administering phenytoin into an intravenous line containing dextrose, or never allowing amphotericin B to come into contact with saline solutions). Other issues to consider are the presence of electrolytes (e.g. potassium chloride) mixing into continuous infusions, such as in a piggyback situation. If mixing medications in a syringe for bolus administration (IV push), assure that they are compatible when combined in a syringe. If consulting a drug reference is not helpful, contact the pharmacy, which has access to additional compatibility information.

Be on alert for medications with a known history of frequent incompatibilities when they come into contact with other drugs. Among the drugs most often incriminated in incompatibilities are furosemide (Lasix), phenytoin (Dilantin), heparin, midazolam (Versed), and diazepam (Valium) when used in IV admixtures.

Drawbacks of PVC

In addition to IV drugs compatibility, clinicians should know that some important issues raise when using PVC as container of infusion solutions. Plasticized polyvinyl chloride (PVC) is one of the most widely used polymeric materials in medical and related fields. In the medical field, flexible PVC is used for the blood storage bags, blood tubing used during hemodialysis, endotracheal tubes, intravenous solution dispensing sets, as well as for drug product storage and packaging. PVC is a rigid polymer, so plasticizers are added to increase its flexibility. Phthalic acid esters, mainly di-(2-ethylhexyl) phthalate (DEHP), are the most preferred plasticizers used in the medical field. Since these additives are not covalently bound to the polymer, there is a possibility for migration of the plasticizer from the matrix. The migration of DEHP from the PVC bags into the solution has been a major concern for many years. The toxicity of DEHP and PVC has raised serious questions about their use. This separation of DEHP from the PVC is called leaching. Leaching occurs when some drugs such as paclitaxel or tamoxifen are administered in PVC bag.

Another concern of using PVC bags are sorption and loss of drug from PVC bags:
  1. Kowaluk et al. examined interactions between 46 injectable drug products and Viaflex (PVC) infusion bags. Study results showed that sorption increases as drug concentration increases
  2. Migration of drug into plastic may lead to subtherapeutic drug concentrations eg.insulin, vit A, acetate, diazepam and nitroglycerin.

Maillard Reaction

Although it is not drug-drug interaction, it is important to address this issue. The Maillard reaction is a chemical reaction between an amino acid and a reducing sugar, usually requiring heat. Like caramelization, it is a form of non-enzymatic browning. The reactive carbonyl group of the sugar reacts with the nucleophilic amino group of the amino acid, and forms a variety of interesting but poorly characterized molecules responsible for a range of odors and flavors. Maillard reaction occurs when amino acids and glucose are contained in single bag. Since amino acids and glucose should be given simultaneously, a clever approach is to produce a dual-chamber bag where glucose and amino acids are separated. They are premixed prior to administration.


Further Readings:

  1. Center for Drug Evaluation and Research (CDER). In Vivo Drug Metabolism/Drug Interaction Studies - Study Design, Data Analysis, and Recommendations for Dosing and Labeling. 1999
  2. Brazier NC, Levine MA. Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionalsAmerican Journal of Therapeutics 2003; 10(3): 163-169
  3. http://www.drugs.com/drug_information.html
  4. Soo An Choi. The role of pharmacist in NST. Proceedings of 11th PENSA Congress. pp256-258.
  5. Kowaluk EA, Roberts MS, Blackburn HD, Polack AE. Interactions between drugs and polyvinyl chloride infusion bags. Am J Hosp Pharm.1981;38(9):1308-14
  6. Larry K. Fry and Lewis D. Stegink Formation of Maillard Reaction Products in Parenteral Alimentation Solutions J. Nutr. 1982 112: 1631-1637
  7. Stadler RH, Blank I, Varga N, Robert F, Hau J, Guy PA, Robert MC, Riediker S. Acrylamide from Maillard reaction products. Nature. 2002 Oct 3;419(6906):449-50.


Appendix 1 Drug Therapy Associated with Micronutrient Abnormalities

↓ Calcium

aminoglycosides, bisphosphonates, corticosteroids, H2 receptor antagonists, loop diuretics ; amphotericin B, antacids, carbamazepine, cholestyramine, cisplatin, colchicines, digoxin, doxycycline, ethosuximide, foscarnet, Mg oxide/sulfate, minocycline, oxcarbazepine, oxytetracycline, pentamidine, phenobarbital, phenytoin, primidone, Na phosphate, sucralfate, zelodronic acid, zonisamide

↑ Calcium

antiestrogens, estrogens, thiazide diuretics ; aluminium intoxication, aminoiphylline, Ca carbonate, lithium

↓Magnesium

aminoglycosides, corticosteroids, estrogens, loop diuretics, oral contraceptives, tetracyclines,thiazide diuretics; amphotericin B, cholestyramine, cisplatin, cyclosporine, digoxin, foscarnet, hydralazine, methsuximide, pamidronate, penicillamine, raloxifene, Na phosphate, tacrolimus, zoledronic acid

↑Magnesium

Usually associated with intake > 6g/day, Mg-containing antacids/enemas

↓Phosphorus

Thiazide diuretics; alendronate, antacids (Al & Mg-containing), cholestyramine, digoxin, foscarnet, Mg oxide/sulfate, ,pamidronate, sucralfate, theophylline, zoledronic acid

↑Phosphorus

Etidronate, foscarnet, Na phosphate laxatives & enemas

↓ Potassium

Aminoglycosides, loop diuretics, penicillins, salicylates, thiazide diuretics, acetazolamide, amphotericin B, bisacodyl, cisplatin, colchicine, cyclosporine, enoxacin, foscarnet, hydralazine, levodopa, mannitol, pamidronate, Na bicarbonate & phosphates

↑ Potassium

ACE inhibitors, angiotensin, receptor blockers, beta-adrenergic blochers, NSAIDs, potassium sparing diuretics ; cyclosporine, heparin, hypertonic solutions, lithium, pentamidine, succinylcholine

↓ Sodium

Aminoglicosides, loop diuretics, potassium sparing diuretics, thiazide diuretics, salicylates ; acetazolamide, amphotericin B, bisacodyl, captopril, colchicine, foscarnet

↑ Sodium

Hypertonic IV solution, mannitol, Na penicillin G, Na phosphate laxative & enemas

↓ Zinc

ACE inhibitors, corticosteroids, diuretics, estrogens, oral contraceptives, H2 receptor antagonists, reverse transcriptase inhibitors ; cholestyramine, ethambutol, hydralazine, penicillamine

↓ Chloride

Thiazide diuretics, loop diuretics

↑ Chloride

Spironolactone, triamterene


Appendix 2 Drug-induced Nutrient Depletion

Drug Class

Nutrients Depleted

5-aminosalacylic acid derivatives

Folic acid

ACE inhibitors

Zinc

Aminoglycosides

Mg, K, Ca, Na

Barbiturates

Biotin, Ca, folic acid, Vitamin D & K

Corticosteroids

Ca, Folic acid, Mg, K, Selenium, Vit C & D, Zinc

Estrogens

Mg, vitamin B2/B6 & C, Zinc

H2 receptor antagonists

Ca, Folic acid, Iron, Vitamin B12 & D, Zinc

Loop diuretics

Ca, Mg, K, Na, Vitamin B1/B6 & C, Zinc

Magnesium and aluminium antacids

Ca, P

NSAIDs

Folic acid

Oral contraceptives

Folic acid, Mg, Tryptophan, Tyrosine, Vitamin B2/B3/B6/B12 & C, Zinc

Proton pump inhibitors

Vitamin B12

Reverse transcript inhibitors

Carnitine, Copper, Vitamin B12, Zinc

Thiazides diuretics

Mg, P, K, Na, Zinc

Tricyclic antidepressants

Vitamin B2

Miscellaneous Drugs

Nutrition Depleted

Acetaminophen

Glutathione

Amphotericin B

Ca, Mg, K, Na

Aspirin

Folic acid, Iron, K, Na, Vitamin C

Bisacodyl

K, Na

Chlorpromazine

Vitamine B2

Cholestyramine

Beta-carotene, Ca, Folic acid, Iron, Mg, P,

Vitamin A/B12/D/E/K, Zinc

Cisplatin

Ca, Mg, K

Clonidine

Zinc

Colchicine

Beta-carotene, Ca, K, Na, Vitamin B12

Colestipol

Beta-carotene, Folic acid, Iron, Vitamin A/B12/D/E

Cyclosporine

Mg, K

Digoxin

Ca, Mg, P, Vitamin B1

Fenofibrate

Vitamin E

Foscarnet

Ca, Mg, P, K

Gemfibrozil

Vitamin E

Hydralazine

Vitamin B6

Indomethacin

Folic acid, Iron

Levodopa

K

Metformin

Folic acid, Vitamin B12

Methotrexate

Folic acid

Methyldopa

Zinc

Orlistat

Beta-carotene, Vitamin D & E

Penicillamine

Copper, Mg, Vitamin B6, Zinc

Potassium chloride (timed-release)

Vitamin B12

Primidone

Biotin, Folic acid, Vitamin D & K

Raloxifene

Mg, Vitamin B2/B6/C, Zinc

Salsalate

Folic acid

Theophylline

P, Vitamin B1/B6

Thioridazine

Vitamin B2

Triamterene

Ca, Folic acid, Zinc

Valproic acid

Carnitine, Folic acid

Zonisamide

Biotin, Inositol, Vitamin B1/B2/B3/B6/B12 & K


Appendix 3 Clinically Significant Drug-Food Interactions

Drug

Interaction

Possible Clinical Outcome

Tetracycline

Decreased bioavailability with milk and dairy products

Therapeutic failure

Ciprofloxacin

Decreased bioavailability with milk and dairy products

Therapeutic failure

Azithromycin

Decreased bioavailability with food

Therapeutic failure

Itraconazole

Decreased bioavailability with food

Possible therapeutic failure

Penicillamine

Decreased bioavailability with food

Therapeutic failure

Didanosine

Food decreases bioavailability

Therapeutic failure

Indinavir

Food decreases bioavailability

Therapeutic failure

Saquinavir

Garlic (allicin) decreases bioavailability

Decreased antiviral activity

Atiovaquone

Food increases bioavailability

Increased efficacy with meals

Lovodopa

Protein decreases transport into the brain

Decreased efficacy

 

Theophylline

Fatty food increases absorption

Possible dose dumping toxicity

Warfarin

Vitamin K rich foods antagonize the anticoagulants

Effect decreased anticoagulation

Cyclosporine

Food and grapefruit juice increase plasma levels

Possible toxicity, lower doses

Alendronate

Food decreases bioavailability

Therapeutic failure

MAO inhibitors

Increased tyramine levels

Hypertensive crisis

Terfanadine

Grapefruit juice increases

Qtc prolongation plasma level

Felodipine

Increased bioavailability

Increased adverse effects

Diuretics

Food decreases bioavailability

Therapeutic failure

Spironolactone

Food decreases bioavailability

Increased efficacy with meals

Propranolol

Increased bioavailability

Increased adverse effects

 

Iyan Darmawan, MD
Medical Director
iyan@ho.otsuka.co.id

 
     
  Other Articles  
 

29 May 2010 | Article

Fluid and Nutrition Management in Acute Pancreatitis


28 May 2010 | Article

Efficacy of Abilify in depressive patients with anxious or atypical features


28 May 2010 | Article

Acute Bronchitis in Children


29 Apr 2010 | Article

Extravasation & Infiltration


28 Apr 2010 | Article

Asthma (A Short Overview)


 
     

 
 
 

Bagaimana menurut anda situs Otsuka ini ?

  

  

  

  

  

Getting poll results. Please wait...
 
  SELL BUY
USD9030.008880.00
SGD6648.656514.65
HKD1163.601142.30
AUD8142.357971.35
JPY105.18102.45
EUR11800.3511577.35

7/30/2010 16:02 WIB



Corporate eMail
 
This site has been accessed 1224241
times
 

 

All Right Reserver by Otsuka PT.